Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.20.2
Summary of Significant Accounting Policies (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Summary of Significant Accounting Policies (Textual)          
Common stock subject to possible redemption, shares 396,781   396,781   33,618
Description of net income (loss) per common share     The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and Private Placement to purchase 6,001,250 shares of common stock and (2) rights sold in the Initial Public Offering and Private Placement that convert into 1,200,250 shares of common stock, in the calculation of diluted income per share, since the exercise of the warrants and the conversion of the rights into shares of common stock is contingent upon the occurrence of future events and the inclusion of such warrants and rights would be anti-dilutive under the treasury stock method.    
Federal depository insurance coverage amount $ 250,000   $ 250,000    
Cash and marketable securities held in trust account 11,276,350   11,276,350   $ 11,877,654
Deferred tax assets 537,000   537,000   407,000
Deferred tax assets, Valuation allowance $ 537,000   $ 537,000   $ 407,000
Income tax expense   $ 70,000   $ 166,000  
Effective tax rate 0.10% 118.00% 0.20% 43.00%  
Income tax benefit (expense) $ (1,480) $ 70,423 $ 3,827 $ 166,238